Showing results (51-60 of 232) with videos related to
Sort By:
Pageof 24
Expert Opinion on Investigational Drugs|July 5, 2005
Gastrointestinal effects of COX-2 inhibitorsL M Jackson, C J HawkeyClinical Nutrition (Edinburgh, Scotland)|February 1, 1992
Therapeutic approaches to the problem of biliary sludge and gallstone formation during total parenteral nutritionF E Murray, C J HawkeyGut|October 1, 1988
Medical treatment of ulcerative colitis: scoring the advancesC J Hawkey, A B HawthorneBest Practice & Research. Clinical Gastroenterology|February 28, 2002
Physiology and organ-related pathology of the elderly: stomach ulcersJ I Jones, C J HawkeyDrugs|July 6, 2000
COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages?L M Jackson, C J HawkeyThe American Journal of Medicine|February 13, 2001
Questions regarding future research on aspirin and the gastrointestinal tractB I Hirschowitz, C J HawkeyInternational Journal of Clinical Practice|June 13, 2003
COX-LOX inhibition: current evidence for an emerging new therapyM M Skelly, C J HawkeyBailliere'S Clinical Gastroenterology|June 1, 1994
Treatment of inflammatory bowel disease from now to the millenniumA T Cole, C J HawkeyAlimentary Pharmacology & Therapeutics|April 1, 1997
Review article: COX-II inhibitors--a new generation of safer NSAIDs?M T Donnelly, C J HawkeyDrugs|August 1, 1989
Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapyA B Hawthorne, C J HawkeyPageof 24